Ingenious raises €184K Seed round
5 April 2017· London, United Kingdom· health, biotech, b2c, manufacturing
The funding was raised as a seed investment for the company (then known as Colltec Laboratories) to develop and commercialize its patented collagen supplement technology.
Investors
LeadSFC Capital
Also participating
Innvotec
About Ingenious
Stage
Series A
Headquarters
London, United Kingdom
Founded
2014
Team Size
21–50
Sectors
healthbiotechb2cmanufacturing